Precigen (PGEN) Interest Coverage Ratio Growth (1y) (2013 - 2026)
Precigen (PGEN) Interest Coverage Ratio Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | -347.04% |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | 73.00% |
| 10 | Precigen | 2.00 Bn | 2.00 Bn | 20.69 Mn | 96.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.21% |
| Sep 30, 2025 | 99.99% |
| Jun 30, 2025 | -254.83% |
| Mar 31, 2025 | -27.28% |
| Sep 30, 2024 | 49.22% |
| Jun 30, 2024 | 95.44% |
| Mar 31, 2024 | -67.95% |
| Dec 31, 2023 | 244.74% |
| Sep 30, 2023 | -559,759.89% |
| Jun 30, 2023 | -1,225.93% |
| Mar 31, 2023 | -305.46% |
| Dec 31, 2022 | -1,720.89% |
| Sep 30, 2022 | 17.23% |
| Jun 30, 2022 | -106.98% |
| Mar 31, 2022 | -60.81% |
| Dec 31, 2021 | 99.75% |
| Sep 30, 2021 | 8.75% |
| Jun 30, 2021 | -119.64% |
| Mar 31, 2021 | -7.80% |
| Dec 31, 2020 | -10,304.87% |